Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
PD-L1
Biotech
Combo may offer route back for Agenus' cervical cancer drug
Fifteen months after the FDA blindsided Agenus with a decision not to offer accelerated approval for balstilimab, the biotech is back with fresh data.
James Waldron
Jan 23, 2023 10:47am
Could beta cells be the source of Type 1 diabetes after all?
Jul 5, 2022 8:25am
Checkpoint on track to add indications for cancer drug approval
Jun 16, 2022 3:49pm
Agenus, with FDA approval in sight, showcases anti-PD-1 data
Aug 27, 2021 7:55am
Arcus, Gilead post scant analysis of clinical data on TIGIT drug
Jun 24, 2021 7:30am
BMS says LAG-3 drug scores with Opdivo
Mar 25, 2021 9:50am
